T1	Participants 71 101	patients with Behcet's disease
T2	Participants 244 326	67 eyes of 35 Behcet's patients with chronic, but well-controlled uveitis, and CMO
T3	Participants 756 915	29 patients (55 eyes) completed the trial and were available for analysis. Of the 29, 16 men and 13 were women. The age range was 13-50 years (mean 33.6 years)
